Immucell ICCC Income Statement (2010-2026)

NASDAQ ICCC
$9.86 -0.05 (-0.51%)
As of: Sep 10, 2026 · 12:25 PM EDT
Reported Financials

Immucell Quarterly Income Statement

Periods 64 quarters
Latest Jun 2026

Immucell reported revenue of $7.19M and net income of $1.83M for the quarter ended Jun 2026, down 10.9% year over year. This income statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
4.54M5.15M5.44M6.00M3.86M4.80M3.91M3.45M3.53M5.40M7.26M5.47M6.01M7.75M8.07M6.44M5.51M7.63M7.19M
Cost of RevenueCost of Rev
2.47M2.73M2.88M2.90M2.15M2.95M2.92M3.15M2.49M4.13M4.96M4.24M4.43M4.92M4.71M3.63M3.14M4.72M4.75M
Gross Profit
2.07M2.42M2.56M3.10M1.71M1.85M0.99M0.30M1.04M1.27M2.30M1.23M1.58M2.83M3.35M2.82M2.36M2.91M2.44M
Operating items
Research & DevelopmentR&D
1.00M1.05M1.09M1.04M1.14M1.27M1.05M1.11M1.10M1.12M1.26M1.03M0.84M0.82M0.86M0.83M0.92M1.08M1.11M
Selling, General & AdministrativeSG&A
0.42M0.44M0.44M0.69M0.53M0.47M0.58M0.57M0.53M0.51M0.53M0.60M0.53M0.55M0.62M0.72M0.73M1.13M1.27M
Restructuring CostsRestructuring
0.69M0.53M
Other Operating ExpensesOther Opex
0.44M0.66M0.89M0.79M-1.02M0.73M0.99M-0.01M77.000.82M0.80M-0.01M0.01M0.43M0.01M-0.06M
Operating ExpensesOpex
1.86M2.15M2.42M2.53M2.33M2.46M2.63M2.56M2.35M2.45M2.60M2.62M2.16M2.21M2.24M2.25M2.34M2.97M0.50M
Operating IncomeOp. Inc
0.22M0.27M0.15M0.57M-0.62M-0.62M-1.63M-2.26M-1.30M-1.18M-0.30M-1.39M-0.57M0.62M1.12M0.57M0.02M-0.06M1.93M
EBIT
0.22M0.27M0.15M0.57M-0.62M-0.62M-1.63M-2.26M-1.30M-1.18M-0.30M-1.39M-0.57M0.62M1.12M0.57M0.02M-0.06M1.93M
Non-operating items
Non Operating Interest Expenses
0.09M0.09M0.15M0.14M0.14M0.14M0.12M0.13M0.11M0.10M
Interest & Investment IncomeInt & Inv Inc
0.04M0.01M0.01M0.01M0.02M0.04M0.04M0.05M0.04M0.03M0.07M
Other Non Operating IncomeOther Non Op Inc.
-0.07M-0.12M-0.07M-0.06M-0.06M-0.03M-0.03M-0.06M-0.07M0.24M-0.06M-0.14M-0.14M
Non Operating IncomeNon Op. Inc.
0.24M-0.13M-0.14M-0.14M-0.13M-0.10M0.33M-0.07M-0.16M-2.79M-0.05M
Net income details
EBT
0.14M0.16M0.08M0.51M-0.68M-0.65M-1.67M-2.31M-1.38M-0.94M-1.14M-0.44M-1.53M-0.70M0.52M1.45M0.50M-0.14M-2.85M1.88M
Tax ProvisionsTaxes
0.01M-0.02M0.00M0.00M0.00M-0.53M0.00M0.00M229.00-1.21M0.00M0.00M0.00M-0.45M0.00M0.00M0.00M-0.22M0.05M
Profit After TaxPAT
0.14M0.15M0.07M0.51M-0.68M-0.66M-1.67M-2.32M-1.38M-0.94M-1.14M-0.44M-1.53M-0.70M0.51M1.45M0.50M-0.14M-2.85M1.83M
Income from Non-Controlling InterestsInc. Minority
0.14M0.15M0.07M0.51M-0.68M-0.66M0.83M-2.32M-1.38M
Income from Continuing OperationsIncome (Continuing)
0.14M0.15M0.10M0.51M-0.68M-0.66M-1.14M-2.32M-1.38M-0.94M0.08M-0.44M-1.53M-0.70M0.98M1.45M0.50M-0.14M-2.62M1.83M
Consolidated Net IncomeConsol Net Inc.
0.14M0.15M0.10M0.51M-0.68M-0.66M-1.14M-2.32M-1.38M-0.94M0.08M-0.44M-1.53M-0.70M0.98M1.45M0.50M-0.14M-2.62M1.83M
Income towards Parent CompanyParent Net Inc
0.14M0.15M0.10M0.51M-0.68M-0.66M-1.14M-2.32M-1.38M-0.94M0.08M-0.44M-1.53M-0.70M0.98M1.45M0.50M-0.14M-2.62M1.83M
Net Income towards Common StockholdersNet Income
0.14M0.15M0.10M0.74M-0.96M-0.66M-1.14M-2.32M-1.38M-0.94M0.08M-0.44M-1.53M-0.70M0.98M1.45M0.50M-0.14M-2.62M1.83M
Additional items
EPS (Basic)
0.020.020.010.10-0.12-0.08-0.15-0.30-0.18-0.120.01-0.06-0.20-0.090.120.160.06-0.02-0.290.20
EPS (Diluted)
0.020.020.010.09-0.12-0.08-0.15-0.30-0.18-0.120.01-0.06-0.20-0.090.120.160.06-0.02-0.290.20
Shares Outstanding
7.66M7.74M7.59M7.74M7.74M7.75M7.75M7.75M7.75M7.75M7.75M7.75M7.81M8.16M8.17M8.98M9.03M9.05M9.03M9.06M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
7.76M7.82M7.59M7.79M7.74M7.75M7.75M7.75M7.75M7.75M7.75M7.75M7.81M8.16M8.17M8.98M9.03M9.05M9.03M9.19M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
7.74M7.74M7.74M7.74M7.75M7.75M7.75M7.75M7.75M7.75M7.75M7.75M7.83M8.83M8.98M8.98M9.05M9.05M9.05M9.08M
EBITDA
0.22M0.27M0.15M0.57M-0.62M-0.62M-1.63M-2.26M-1.30M-1.18M-0.30M-1.39M-0.57M0.62M1.12M0.57M0.02M-0.06M1.93M
Interest ExpensesInt Expense
0.09M0.09M0.15M0.14M0.14M0.14M0.12M0.13M0.11M0.10M
Tax Rate
5.16%-29.98%0.22%-0.17%-0.59%31.70%-0.07%-0.11%-0.02%106.72%-0.31%-0.09%-0.19%-87.36%0.13%0.38%-3.29%7.88%2.44%